![](https://340breport.com/wp-content/uploads/2024/04/Feldesman-Logo-300x200-1.png)
SPONSORED CONTENT On April 19, 2024—fourteen years after the Congressional deadline—the Health Resources and Services Administration published its final rule […]
SPONSORED CONTENT On April 19, 2024—fourteen years after the Congressional deadline—the Health Resources and Services Administration published its final rule […]
SPONSORED CONTENT Imagine the services you could offer to the community your facility serves if you had additional funding. If […]
SPONSORED CONTENT All entities who participate in the 340B program are subject to an Office of Pharmacy Affairs (OPA) audit […]
SPONSORED CONTENT Consolidated Service Centers (CSCs) centralize many pharmacy services along with the inventory of a health system and capture […]
SPONSORED CONTENT The 340B program remains essential in ensuring equitable access to crucial medications for vulnerable, underserved populations. The program […]
SPONSORED CONTENT Since 2020, select drug manufacturers have begun deploying restrictions or limitations on the sale of their products through […]
SPONSORED CONTENT Every dollar counts when you’re serving an underserved population. However, many organizations fail to incorporate a holistic approach […]
SPONSORED CONTENT As we welcome the fresh energy of spring, now is the perfect time for 340B covered entities to […]
SPONSORED CONTENT Attention 340B Covered Entities: For most covered entities, the 340B program is essential to their organization’s bottom line […]
SPONSORED CONTENT Attention 340B Covered Entities: The 340B drug pricing program is entering an exciting phase of evolution. The SUSTAIN […]
*Sign up for news summaries and alerts from 340B Report